Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lackner

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Brain Sciences|April 30, 2021
Transcutaneous Spinal Cord Stimulation Enhances Walking Performance and Reduces Spasticity in Individuals with Multiple SclerosisUrsula S Hofstoetter, Brigitta Freundl, Peter Lackner, et al.
Current Drug Targets|October 27, 2017
Editorial:Brain Hemorrhages and Future ManagementGang Chen, Peter Lackner, Ihsan Solaroğlu, et al.
Bioinformatics (Oxford, England)|January 9, 2016
MAESTROweb: a web server for structure-based protein stability predictionJosef Laimer, Julia Hiebl-Flach, Daniel Lengauer, et al.
Frontiers in Immunology|May 6, 2022
Cerebral Malaria: Current Clinical and Immunological AspectsKarin Albrecht-Schgoer, Peter Lackner, Erich Schmutzhard, et al.
The Journal of Chemical Physics|February 17, 2020
Few-monolayer yttria-doped zirconia films: Segregation and phase stabilizationPeter Lackner, Amy J Brandt, Ulrike Diebold, et al.
Cell Reports. Medicine|November 12, 2024
Transcutaneous spinal cord stimulation neuromodulates pre- and postsynaptic inhibition in the control of spinal spasticityKaren Minassian, Brigitta Freundl, Peter Lackner, et al.
The Review of Scientific Instruments|November 3, 2017
Construction and evaluation of an ultrahigh-vacuum-compatible sputter deposition sourcePeter Lackner, Joong Il Jake Choi, Ulrike Diebold, et al.
BMC Bioinformatics|April 18, 2015
MAESTRO--multi agent stability prediction upon point mutationsJosef Laimer, Heidi Hofer, Marko Fritz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinomaThomas Kleinrath, Christoph Gassner, Peter Lackner, et al.
Bioinformatics (Oxford, England)|December 25, 2003
WILMA-automated annotation of protein sequencesAndreas Prlić, Francisco S Domingues, Peter Lackner, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Brain Sciences|April 30, 2021
Transcutaneous Spinal Cord Stimulation Enhances Walking Performance and Reduces Spasticity in Individuals with Multiple SclerosisUrsula S Hofstoetter, Brigitta Freundl, Peter Lackner, et al.
Current Drug Targets|October 27, 2017
Editorial:Brain Hemorrhages and Future ManagementGang Chen, Peter Lackner, Ihsan Solaroğlu, et al.
Bioinformatics (Oxford, England)|January 9, 2016
MAESTROweb: a web server for structure-based protein stability predictionJosef Laimer, Julia Hiebl-Flach, Daniel Lengauer, et al.
Frontiers in Immunology|May 6, 2022
Cerebral Malaria: Current Clinical and Immunological AspectsKarin Albrecht-Schgoer, Peter Lackner, Erich Schmutzhard, et al.
The Journal of Chemical Physics|February 17, 2020
Few-monolayer yttria-doped zirconia films: Segregation and phase stabilizationPeter Lackner, Amy J Brandt, Ulrike Diebold, et al.
Cell Reports. Medicine|November 12, 2024
Transcutaneous spinal cord stimulation neuromodulates pre- and postsynaptic inhibition in the control of spinal spasticityKaren Minassian, Brigitta Freundl, Peter Lackner, et al.
The Review of Scientific Instruments|November 3, 2017
Construction and evaluation of an ultrahigh-vacuum-compatible sputter deposition sourcePeter Lackner, Joong Il Jake Choi, Ulrike Diebold, et al.
BMC Bioinformatics|April 18, 2015
MAESTRO--multi agent stability prediction upon point mutationsJosef Laimer, Heidi Hofer, Marko Fritz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinomaThomas Kleinrath, Christoph Gassner, Peter Lackner, et al.
Bioinformatics (Oxford, England)|December 25, 2003
WILMA-automated annotation of protein sequencesAndreas Prlić, Francisco S Domingues, Peter Lackner, et al.
Pageof 12